Attunio Health Scales Psychiatric Platform via Quest and Getlabs

The expansion signals a departure from the episodic model of mental healthcare, which typically relies on infrequent visits and trial-and-error prescribing. Attunio’s system, branded as Closed-Loop Precision Psychiatry, synthesizes data from wearables, AI-driven behavioral analysis, and standardized medical testing. By integrating Quest Diagnostics, the company gains the capacity to screen patients for metabolic imbalances, inflammation, and hormonal disruptions—biological markers often overlooked in traditional psychiatric settings.

Accessibility remains a primary hurdle for data-heavy care models. The integration of Getlabs addresses this by deploying certified phlebotomists directly to patients’ homes or workplaces. This logistical shift allows clinicians to monitor neurobiological performance and drug safety without requiring office visits. The company intends to use these data streams to differentiate between clinical conditions that present with similar symptoms, such as distinguishing between sleep-deprivation-induced focus issues and ADHD progression. Through this infrastructure, Attunio aims to identify signs of patient deterioration before a crisis occurs, moving the field toward a predictive, personalized standard of care.